Cargando…

Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation

Out of the breast cancer subtypes, triple-negative breast cancer (TNBC) has the poorest prognosis without effective targeted therapies. Metformin, a first-line drug for type 2 diabetes mellitus, was demonstrated to target breast cancer stem cells selectively. However, the efficiency and the mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Peiguo, Liu, Wenjing, Tala, Wang, Haixia, Li, Fubing, Zhang, Hailin, Wu, Yingying, Kong, Yanjie, Zhou, Zhongmei, Wang, Chunyan, Chen, Wenlin, Liu, Rong, Chen, Ceshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396048/ https://www.ncbi.nlm.nih.gov/pubmed/28480051 http://dx.doi.org/10.1038/celldisc.2017.10

Ejemplares similares

The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27(Kip1)
por: Wang, Chunyan, et al.
Publicado: (2015)

Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression
por: Liu, Rong, et al.
Publicado: (2016)

BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5
por: Qin, Junying, et al.
Publicado: (2015)

Cucurbitacin E Induces Cell Cycle G2/M Phase Arrest and Apoptosis in Triple Negative Breast Cancer
por: Kong, Yanjie, et al.
Publicado: (2014)

Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast Cancer
por: Kong, Yanjie, et al.
Publicado: (2022)

Mifepristone Derivative FZU-00,003 Suppresses Triple-negative Breast Cancer Cell Growth partially via miR-153-KLF5 axis
por: Liu, Rong, et al.
Publicado: (2020)

Mithramycin A suppresses basal triple-negative breast cancer cell survival partially via down-regulating Krüppel-like factor 5 transcription by Sp1
por: Liu, Rong, et al.
Publicado: (2018)

KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8(+) T-cell-dependent antitumor immunity
por: Wu, Qi, et al.
Publicado: (2023)

Ataxin-3 like (ATXN3L), a member of the Josephin family of deubiquitinating enzymes, promotes breast cancer proliferation by deubiquitinating Krüppel-like factor 5 (KLF5)
por: Ge, Fei, et al.
Publicado: (2015)

miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5
por: Zhou, Wenhui, et al.
Publicado: (2017)

RNF126‐Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple‐Negative Breast Cancer to Radiotherapy
por: Liu, Wenjing, et al.
Publicado: (2022)

TNF-α increases breast cancer stem-like cells through up-regulating TAZ expression via the non-canonical NF-κB pathway
por: Liu, Wenjing, et al.
Publicado: (2020)

The roles and regulation of the KLF5 transcription factor in cancers
por: Luo, Yao, et al.
Publicado: (2021)

Hypoxia induces miR-153 through the IRE1α-XBP1 pathway to fine tune the HIF1α/VEGFA axis in breast cancer angiogenesis
por: Liang, Huichun, et al.
Publicado: (2018)

Isochromanoindolenines suppress triple-negative breast cancer cell proliferation partially via inhibiting Akt activation
por: Jiang, Xiaoyan, et al.
Publicado: (2021)

Targeting HECTD3-IKKα axis inhibits inflammation-related metastasis
por: Li, Fubing, et al.
Publicado: (2022)

Angiopoietin-1 promotes triple-negative breast cancer cell proliferation by upregulating carboxypeptidase A4: ANG1-CPA4 axis promotes TNBC progression
por: Liu, Xue, et al.
Publicado: (2023)

KHF16 is a Leading Structure from Cimicifuga foetida that Suppresses Breast Cancer Partially by Inhibiting the NF-κB Signaling Pathway
por: Kong, Yanjie, et al.
Publicado: (2016)

Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer
por: Zou, Hailin, et al.
Publicado: (2023)

Pyrrolo [3,4-b]-quinolin-9-amine compound FZU-0038-056 suppresses triple-negative breast cancer partially through inhibiting the expression of Bcl-2
por: Wang, Danping, et al.
Publicado: (2020)

Inhibition of super enhancer downregulates the expression of KLF5 in basal-like breast cancers
por: Chen, Chuan-Huizi, et al.
Publicado: (2019)

Role of KLF15 in Regulation of Hepatic Gluconeogenesis and Metformin Action
por: Takashima, Mototsugu, et al.
Publicado: (2010)

Ilamycin E, a natural product of marine actinomycete, inhibits triple-negative breast cancer partially through ER stress-CHOP-Bcl-2
por: Zhou, Wenhui, et al.
Publicado: (2019)

Integrin β4 promotes DNA damage-related drug resistance in triple-negative breast cancer via TNFAIP2/IQGAP1/RAC1
por: Fang, Huan, et al.
Publicado: (2023)

Cyst(e)ine in nutrition formulation promotes colon cancer growth and chemoresistance by activating mTORC1 and scavenging ROS
por: Wu, Jiao, et al.
Publicado: (2021)

Tanshinol Rescues the Impaired Bone Formation Elicited by Glucocorticoid Involved in KLF15 Pathway
por: Yang, Yajun, et al.
Publicado: (2016)

Metformin Inducing the Change of Functional and Exhausted Phenotypic Tumor-Infiltrated Lymphocytes and the Correlation with JNK Signal Pathway in Triple-Negative Breast Cancer
por: Wang, Ruibin, et al.
Publicado: (2022)

Dexamethasone induces docetaxel and cisplatin resistance partially through up-regulating Krüppel-like factor 5 in triple-negative breast cancer
por: Li, Zhen, et al.
Publicado: (2016)

Characterization and phylogenetic analysis of Krüppel-like transcription factor (KLF) gene family in tree shrews (Tupaia belangeri chinensis)
por: Shao, Ming, et al.
Publicado: (2016)

YD277 Suppresses Triple-Negative Breast Cancer Partially Through Activating the Endoplasmic Reticulum Stress Pathway
por: Chen, Zekun, et al.
Publicado: (2017)

Inhibitory effect of the novel tyrosine kinase inhibitor DCC-2036 on triple-negative breast cancer stem cells through AXL-KLF5 positive feedback loop
por: Shen, Yingying, et al.
Publicado: (2022)

Metformin Targets Glucose Metabolism in Triple Negative Breast Cancer
por: Wahdan-Alaswad, RS, et al.
Publicado: (2018)

Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer
por: Chen, Bo, et al.
Publicado: (2018)

Tongshu Capsule Down-Regulates the Expression of Estrogen Receptor α and Suppresses Human Breast Cancer Cell Proliferation
por: Du, Chengzhi, et al.
Publicado: (2014)

KLF15 suppresses tumor growth and metastasis in Triple-Negative Breast Cancer by downregulating CCL2 and CCL7
por: Kanyomse, Quist, et al.
Publicado: (2022)

Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer
por: Zhao, Ping, et al.
Publicado: (2023)

miR-153 inhibits the migration and the tube formation of endothelial cells by blocking the paracrine of angiopoietin 1 in breast cancer cells
por: Liang, Huichun, et al.
Publicado: (2018)

Pioglitazone protects blood vessels through inhibition of the apelin signaling pathway by promoting KLF4 expression in rat models of T2DM
por: Wang, Ying, et al.
Publicado: (2019)

SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer
por: Liu, Peng, et al.
Publicado: (2018)

The Partial Role of KLF4 and KLF5 in Gastrointestinal Tumors
por: Li, Jun-Chen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_39027kg31me0vmbd003b1d5ia1